Chopchini (China Root) in Ayurveda: Properties & Everyday Use

What it is

Chopchini (also spelled chobchini; Sanskrit synonyms include dvipantara vacha and madhusnuhi) is the dried rhizome of Smilax china L., a climbing shrub. The accepted botanical source of the Ayurvedic drug is Smilax china Linn.; related species such as S. zeylanica are reported as alternate sources in some regions (pharmacognosy paper; Smilax review). The plant is not native to India, the rhizome was historically imported from China (hence "china root"), and its first Ayurvedic mention appears in the Bhavaprakasha of the 16th century (pharmacognosy paper). The flavonoid quercetin has been isolated from the rhizome and studied pharmacologically (PMC study).

Classical properties

• Taste (rasa): bitter (Tikta), pungent (Katu)
• Qualities (guna): light (Laghu), dry (Ruksha)
• Potency (virya): warming (Ushna)
• After digestion (vipaka): pungent (Katu)
• Doshas: traditionally said to settle Vata and Kapha; may increase Pitta

Traditional use

Classical and later Ayurvedic texts describe chopchini as an "alterative" root and record it for venereal disease (notably syphilis, firanga), pains and rheumatism, epilepsy, and nervous-system complaints including hysteria and psychosis as described in the traditional literature (pharmacognosy paper). A historical survey of the drug's identity notes its long-standing reputation as an "alterative" in the sarsaparilla tradition, imported in quantity to Indian markets from China (Perera, 2014). These are traditional descriptions, not clinical proof; the research record is examined separately below.

What research has looked at

Skin inflammation (animal and cell studies)

Quercetin isolated from Smilax china rhizome was tested for anti-psoriatic activity: it produced significant orthokeratosis in the mouse-tail test, reduced epidermal thickness, inhibited leukocyte migration (an anti-inflammatory measure), and showed antiproliferative activity in human keratinocyte (HaCaT) cell culture (PMC study). The authors called it the first report of anti-psoriatic activity for this flavonoid and framed it as a lead for further investigation: not a treatment finding.

Pelvic inflammation (animal study)

Flavonoids purified from Smilax china rhizome were tested in a rat model of pelvic inflammatory disease. Treated rats showed significantly reduced uterine inflammation and fibrosis, with inhibition of ERK1/2 and TGF-β/Smad2/3 signaling pathways (Tian et al., J Functional Foods 2016). This is a single animal study of a purified fraction, not evidence for the whole rhizome in people.

What the evidence does not support (yet)

No human clinical trials of Smilax china were identified for syphilis, skin disease, rheumatism, or any other indication. Much of the broader Smilax research literature concerns the related species S. glabra (for example, astilbin studies in arthritic rats): findings from a different species cannot be transferred to chopchini.

Safety notes

No human safety data for chopchini were identified. The animal studies above used purified fractions or isolated compounds at research doses, which say nothing about the safety of crude rhizome preparations in people. A practical concern is identity: several Smilax species are sold under the chopchini/china-root name, so the actual species in a product may differ from S. china (pharmacognosy paper). There are no data on pregnancy, breastfeeding, or drug interactions.

FAQs

What is chopchini?

Chopchini is the dried rhizome of Smilax china L., known in English as china root. It entered Ayurveda around the 16th century as an imported drug from China (pharmacognosy paper).

What is chopchini used for in Ayurveda?

Traditional texts record it for syphilis and other venereal complaints, pains and rheumatism, epilepsy, and nervous-system complaints (pharmacognosy paper). These are traditional uses, not clinically proven effects.

Does research support chopchini for skin disease?

Only preclinically. Quercetin from the rhizome showed anti-inflammatory and anti-psoriatic-like activity in mouse and cell models (PMC study). No human trials exist.

Is chopchini the same as sarsaparilla?

Not exactly. "Sarsaparilla" usually refers to New World Smilax species, but chopchini (S. china) has historically been grouped in the same alterative tradition and used as a sarsaparilla substitute (Perera, 2014).

Is chopchini safe?

Human safety data are lacking. Animal studies used purified fractions, not crude preparations. Species substitution in the market is an additional concern: consult a qualified practitioner before use.

What is the recommended dose of chopchini?

Swastik does not suggest amounts. The right amount depends on the person, the preparation and the product, so check with a qualified Ayurvedic practitioner or your doctor before taking any herb.

Sources

• "Pharmacognostical and Phytochemical Studies on Smilax perfoliata" (Int J Botany Studies 2021; accepted source of Chopachini = Smilax china Linn.; Bhavaprakasha 16th-century first mention; traditional uses) — botanyjournals.com
• Perera BPR. "A Study on the Plants Used as Chopachini" — J Homeop Ayurv Med. 2014;3:170 (identity and trade history of the drug) — omicsonline.org
• "Screening of flavonoid 'quercetin' from the rhizome of Smilax china Linn. for anti-psoriatic activity" (animal and cell study) — PMC · PMC3609293
• Tian L-W et al. "Protection of flavonoids from Smilax china L. rhizome on phenol mucilage-induced pelvic inflammation in rats" — J Functional Foods. 2016 (animal study) — DOI · 10.1016/j.jff.2016.11.015

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.